Starting
Initialising…
0%
ATM
Final classification
Pathogenic
ATM c.5983G>T · p.Glu1995Ter
ATM

NM_000051.4:c.5983G>T (p.Glu1995Ter) is a nonsense variant in exon 40 of 63 of ATM, a gene where loss of function is a well-established mechanism for autosomal recessive ataxia-telangiectasia. The premature termination codon lies well upstream of the final exon and is predicted to trigger nonsense-mediated decay, removing all critical C-terminal domains (FAT, PI3K, FATC). Under the ATM VCEP v1.5 PVS1 decision tree, this meets PVS1 at Very Strong strength.

Gene
ATM
Transcript
NM_000051.4
HGVS · transcript:coding
NM_000051.4:c.5983G>T
Consequence
N/A
GRCh38
chr11:108312475 G>T
GRCh37
chr11:108183202 G>T
Basis Richards et.al., 2015 - Combining rules v1.5.0 criteria-combination framework: matched Rule4 (1 Pathogenic.Very Strong + Pathogenic.Supporting >=2) with applied criteria: PVS1 very strong, PM2 supporting, PM5 supporting; maps to Pathogenic.
Richards et.al., 2015 - Combining rules v1.5.0 criteria-combination framework: matched Rule4 (1 Pathogenic.Very Strong + Pathogenic.Supporting >=2) with applied criteria: PVS1 very strong, PM2 supporting, PM5 supporting; maps to Pathogenic.
Classification rationale
PVS1PM2PM5 Pathogenic
ATM c.5983G>T

NM_000051.4:c.5983G>T (p.Glu1995Ter) is a nonsense variant in exon 40 of 63 of ATM, a gene where loss of function is a well-established mechanism for autosomal recessive ataxia-telangiectasia. The premature termination codon lies well upstream of the final exon and is predicted to trigger nonsense-mediated decay, removing all critical C-terminal domains (FAT, PI3K, FATC). Under the ATM VCEP v1.5 PVS1 decision tree, this meets PVS1 at Very Strong strength.1 The variant is absent from gnomAD v4.1 and v2.1 (0 alleles observed), meeting the ATM VCEP v1.5 PM2_Supporting threshold of allele frequency ≤0.001% in the gnomAD v4 dataset.2 As a truncating variant with a premature termination codon at p.Glu1995, located upstream of p.Arg3047, PM5_Supporting applies per ATM VCEP v1.5 specifications.3 No experimental functional data (PS3/BS3), case-control enrichment data (PS4), de novo observations (PS5), or co-segregation data (PP1) were identified for this specific variant in the reviewed literature. None of the three publications reviewed (PMID:27413114, PMID:30348496, PMID:30553448) mentioned NM_000051.4:c.5983G>T. Applying the ATM VCEP v1.5 final classification rules (Richards et al. 2015 combination framework): PVS1 (Very Strong) plus two Supporting pathogenic criteria (PM2_Supporting, PM5_Supporting) satisfies Rule 4 (1 Pathogenic Very Strong + ≥2 Pathogenic Supporting), resulting in a final classification of Pathogenic.4

PVS1 + PM2 + PM5 Pathogenic
1 vcep_atm_pvs1_1_5vcep_suppl_tables1_pmid_40580951pvs1_generic_framework ↗
4 cspec ↗final_classification_framework
Gene diagram · NM_000051.4 · variants mapped to exon structure
ATM NM_000051.4
Fetching transcript structure from UCSC…
Applied criteria · 3 met · select any tile
Met
Not met
Not assessed
N/A
Strength very strong supporting
Pathogenic evidence
PVS
PS
PM
PP
Benign evidence
BA
BS
BP
Rationale
Select a criterion.
Sources
Evidence used
    Gaps remaining
      Rule
      Research & evidence
      Population frequency · supports pathogenic
      gnomAD v4.1 screenshot
      gnomAD v4.1
      gnomAD v2.1 screenshot
      gnomAD v2.1
      Population frequency
      Absent from gnomAD v4.1.
      Absent from gnomAD v2.1.
      This variant is absent from gnomAD-Canada.
      ClinVar screenshot
      ClinVar
      This variant is present in ClinVar (Variation ID: 4077029); submission details unavailable.
      SpliceAI screenshot
      In silico
      SpliceAI predicts no significant splice impact for this variant (max delta score = 0.00). BayesDel score = 0.634849.
      Functional / OncoKB screenshot
      Functional Likely Oncogenic
      OncoKB identified variant-specific curated literature and context relevant to functional review; biological-effect context: Likely Loss-of-function; curated oncogenicity label: Likely Oncogenic.
      OncoKB ↗
      COSMIC screenshot
      COSMIC
      Cancer hotspots screenshot
      Cancer hotspots
      Somatic evidence Not in COSMIC / hotspots
      COSMIC
      This variant does not lie in a statistically significant hotspot. This variant has previously been reported in somatic cancers (COSMIC; COSV53771051, n = 2 times).
      Hotspots
      This variant does not lie in a statistically significant hotspot.
      Literature · 3 PMIDs triaged · 3 high-priority
      3papers screened
      Papers triaged by theme: functional/splicing/segregation/case_observation. high_priority_papers include abstract snippets. Use these to support PS3/BS3/PS4/PP1/PP3/PP5.
      27413114 ↗ functional
      ATM Mutations in Cancer: Therapeutic Implications.
      Activation of checkpoint arrest and homologous DNA repair are necessary for maintenance of genomic integrity during DNA replication. Germ-line mutations of the ataxia telangiectasia mutated (ATM) gene result in the well-characterized ataxia telangiectasia syndrome, which manifests with an increased cancer predisposition, including a 20% to 30% lifetime risk of lymphoid, gastric, breast, central ne
      BS3PM1PS3
      30348496 ↗ functional
      Inactive Atm abrogates DSB repair in mouse cerebellum more than does Atm loss, without causing a neurological phenotype.
      The genome instability syndrome, ataxia-telangiectasia (A-T) is caused by null mutations in the ATM gene, that lead to complete loss or inactivation of the gene's product, the ATM protein kinase. ATM is the primary mobilizer of the cellular response to DNA double-strand breaks (DSBs) - a broad signaling network in which many components are ATM targets. The major clinical feature of A-T is cerebell
      BS3PM1PS3
      30553448 ↗ functional
      Loss of ATM positively regulates Rac1 activity and cellular migration through oxidative stress.
      Ataxia-telangiectasia mutated (ATM) is a serine-threonine kinase that is integral in the response to DNA double-stranded breaks (DSBs). Cells and tissues lacking ATM are prone to tumor development and enhanced tumor cell migration and invasion. Interestingly, ATM-deficient cells exhibit high levels of oxidative stress; however, the direct mechanism whereby ATM-associated oxidative stress may contr
      BS3PM1PS3
      Sources & reference links
      8Sources
      CSpec VCEP
      ClinVar
      gnomAD v2.1
      gnomAD v4.1
      SpliceAI
      OncoKB
      COSMIC
      Cancer hotspots